A review of the United Kingdom (UK) multiple sclerosis (MS) literature suggests that over the last three decades prevalence and estimated incidence rates have increased, while mortality rates have been declining. UK mortality data over a 30 year period have been studied to examine temporal and geographical variations, to estimate changes in survival, and to examine the relationship between mortality and morbidity trends. The study has shown an overall decline in mortality throughout the UK of approximately 25% over the 30 year period ending in 1983, and a reduction in the mortality differential between Scotland, and England and Wales, but no positive correlation has been found between mortality and morbidity. The overall decline in death rate in females was 23% and in males 30% over the 30 years of the survey. The total number of deaths declined by 39% between the five year periods 1954-58 and 1979-83 in Scotland compared with a 10% decline for England and Wales. Estimated median age of death increased from 52 to 59 years and the improvement in survival over the period of study was similar for both countries and is unlikely to have contributed to the reduction in mortality differential.
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Within England and Wales regional mortality rates did not show a clear north-south gradient. The decline in the mortality differential between Scotland and England (if not artefactual) may provide an important aetiological clue in the search for the cause of multiple sclerosis, and the rate of decline suggests an environmental rather than a genetic aetiology.
Since Limburg hypothesised almost 40 years ago that the frequency of multiple sclerosis (MS) is related to the distance of the surveyed area from the equator,' epidemiological research seeking clues to the aetiology of the disease has been dominated by consideration of the geographic distribution of the disease. In the early 1950s, for example, McAlpine and Compston's study of United Kingdom (UK) mortality rates supported the idea of a north-south gradient,2 and several subsequent prevalence surveys have also given support to the idea that Limburg's theory holds for the UK (table 1) .?" Recently Swingler and Compston have suggested that the gradient in prevalence in the UK correlates with regional differences in the frequency distribution of HLA-DR2 antigens in normal individuals. '4 An examination of temporal trends in multiple sclerosis may, however, be important in the search for aetiological factors. A recent review of UK mortality data, on the other hand, has shown a significant decline in mortality throughout the UK between 1921-80.'4 While an increase in survival will lead to an increase in prevalence with a corresponding decrease in mortality over the short term, it is not clear to what extent changes in survival account for the changes in prevalence described above.
The epidemiological picture of multiple sclerosis in the UK is therefore somewhat unclear with morbidity and mortality data showing temporal disease trends going in apparently different directions. To describe temporal and geographical trends in mortality we have studied UK mortality data over a 30 year period. The objectives of the survey were: 1) to examine temporal and geographical variations in mortality; 2) to estimate changes in survival as far as is possible from the available data, and 3) to examine the relationship between mortality and morbidity trends.
Methods
Annual numbers of deaths attributed to multiple sclerosis (as underlying cause)'5 16 and estimates of population in England and Wales, Scotland and Northern Ireland were taken from published sources for the period 1954-83, (Null model deviance 3708-4 on 569 df). Crude mortality rate per 100 000 per year Figure 3 Prevalence ratios and crude mortality rates per 100 000 by area over time. Reliance on mortality data may, however, lead to underestimation of prevalence. Published mortality data are based on underlying cause and where MS is certified as a contributing cause of death it is not routinely coded. The resulting degree of underestimation was shown to be around 30% for England and Wales and nearly 50% for Scotland. As demonstrated in this paper the proportion of underestimation appears to be consistent over time for both countries, and so mortality data based on underlying cause can be a valuable tool for observing trends and uncovering geographical difference.
Mortality data have two strengths: its completeness, as virtually all deaths are certified and coded, and the reliability of the diagnosis (the doctor is unlikely to mention MS on the certificate unless the diagnosis has been estab-lished with reasonable certainty). A further obvious advantage is that mortality data is collected on a routine basis, and so are widely available.
Morbidity (prevalence) data, on the other hand, suffers from incomplete geographic availability and from the disadvantage of diagnostic uncertainty. This is especially likely to be a problem in early cases as there is no definite confirmatory test which is positive in all cases. It seems possible that, under survey conditions where the aim is to ascertain cases, there is a danger of over diagnosing. Therefore diagnostic bias as a result of case finding, although it has never been measured, remains a possibility. Changes in diagnostic habits and different methods of ascertainment make comparisons between population surveys carried out at different times extremely difficult to interpret.
LATITUDINAL GRADIENT?
In his paper on the prevalence of MS in northern Scotland, Sutherland suggested MS was more common in Scotland than elsewhere in the UK.5 This view has been generally accepted, having been supported by the numerous population studies which make Scotland the most surveyed area in the world.7" Recently, however, Williams and McKeran in studying prevalence in South London questioned the extent of the northsouth gradient. '3 This review provides evidence that the differential in mortality between Scotland and England has been declining during the survey period. Also there is no clear evidence of a latitudinal gradient in mortality south of the Scottish border.
If it is accepted that at the beginning of the survey period a real north-south gradient existed, then it seems plausible that an environmental factor has been operating to cause the gradient, and that its effect has been dissipating over time, more markedly in Scotland than England. The possibility, however, that an artefact was responsible for the original mor-
